Protection against titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonist

Biomaterials

Volumn 31, Issue 8, 2010, Pages 1996-2000

  Geng, Dechun ^a   Xu, Yaozeng ^a   Yang, Huilin ^a   Wang, Junhua ^a   Zhu, Xuesong ^a   Zhu, Guangming ^a   Wang, Xianbin ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Air pouch; AM630; Cannabinoid receptor 2; Osteolysis; Wear particle

Indexed keywords

ASEPTIC LOOSENING; BALB/C MICE; BONE IMPLANTATION; CANNABINOID RECEPTORS; EFFECTIVE MEASURES; GENE ACTIVITIES; INFLAMMATORY RESPONSE; INTRAPERITONEALLY; MOLECULAR ANALYSIS; OSTEOLYSIS; PERI-IMPLANT BONES; PERIPROSTHETIC OSTEOLYSIS; POTENTIAL VALUES; TI PARTICLES; TITANIUM PARTICLES; TOTAL JOINT ARTHROPLASTY; TREATMENT GROUP; WEAR DEBRIS; WEAR PARTICLES;

DEBRIS; DRUG THERAPY; HISTOLOGY; TITANIUM;

BONE;

6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CANNABINOID 2 RECEPTOR; CREATINE KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SODIUM CHLORIDE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; CALVARIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMPLANTATION; INHIBITION KINETICS; MECHANICAL STRESS; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS STRAIN RELATIONSHIP;

ANIMALS; FEMALE; HUMANS; INDOLES; MICE; MICE, INBRED BALB C; OSTEOCLASTS; OSTEOLYSIS; PARTICLE SIZE; PROSTHESIS FAILURE; RANK LIGAND; RECEPTOR, CANNABINOID, CB2; SKULL; TITANIUM;

MURINAE; MUS;

EID: 74449088472     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.11.069     Document Type: Article

References (27)

1. Wooley P.H., and Schwarz E.M. Aseptic loosening. Gene Ther 11 4 (2004) 402-407
2. Purdue P.E., Koulouvaris P., Potter H.G., Nestor B.J., and Sculco T.P. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res 454 (2007) 251-261
3. Holt G., Murnaghan C., Reilly J., and Meek R.M. The biology of aseptic osteolysis. Clin Orthop Relat Res 460 (2007) 240-252
4. Goodman S.B. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials 28 34 (2007) 5044-5048
5. Ren W.P., Markel D.C., Zhang R., Peng X., Wu B., Monica H., et al. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 27 30 (2006) 5161-5169
6. Ren W., Wu B., Peng X., Hua J., Hao H.N., and Wooley P.H. Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK(-/-) mice. J Orthop Res 24 8 (2006) 1575-1586
7. Holding C.A., Findlay D.M., Stamenkov R., Neale S.D., Lucas H., Dharmapatni A.S., et al. The correlation of RANK, RANKL and TNF-α expression with bone loss volume and polyethylene wear debris around hip implants. Biomaterials 27 30 (2006) 5212-5219
8. Vallés G., Gil-Garay E., Munuera L., and Vilaboa N. Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles. Biomaterials 29 15 (2008) 2326-2335
9. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A 97 4 (2000) 1566-1571
10. Idris A.I., van 't Hof R.J., Greig I.R., Ridge S.A., Baker D., Ross R.A., et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 11 7 (2005) 774-779
11. Ofek O., Karsak M., Leclerc N., Fogel M., Frenkel B., Wright K., et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci U S A 103 3 (2006) 696-701
12. Idris A.I., Sophocleous A., Landao-Bassonga E., van't Hof R.J., and Ralston S.H. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology 149 11 (2008) 5619-5626
13. Lunn C.A., Fine J., Rojas-Triana A., Jackson J.V., Lavey B., Kozlowski J.A., et al. Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss. Immunopharmacol Immunotoxicol 29 3-4 (2007) 387-401
14. Rossi F., Siniscalco D., Luongo L., De Petrocellis L., Bellini G., Petrosino S., et al. The endovanilloid/endocannabinoid system in human osteoclasts: possible involement in bone formation and resorption. Bone 44 3 (2009) 476-484
15. George K.L., Saltman L.H., Stein G.S., Lian J.B., and Zurier R.B. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. J Cell Physiol 214 3 (2008) 714-720
16. Howlett A.C. The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69 (2002) 619-631
17. Smith M.V., Lee M.J., Islam A.S., Rohrer J.L., Goldberg V.M., Beidelschies M.A., et al. Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-α production in response to titanium particles in vitro. J Bone Joint Surg Am 89 5 (2007) 1019-1027
18. Bi Y., Van De Motter R.R., Ragab A.A., Goldberg V.M., Anderson J.M., and Greenfield E.M. Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. J Bone Joint Surg Am 83A 4 (2001) 501-508
19. Schwarz E.M., Benz E.B., Lu A.P., Goater J.J., Mollano A.V., Rosier R.N., et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 18 6 (2000) 849-855
20. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 4 (2001) 402-408
21. Ren W., Yang S.Y., and Wooley P.H. A novel murine model of orthopaedic wear debris associated osteolysis. Scand J Rheumatol 33 5 (2004) 349-357
22. Wooley P.H., Morren R., Andary J., Sud S., Yang S.Y., Mayton L., et al. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23 2 (2002) 517-526
23. Ren W.P., Yang S.Y., Fang H.W., Hsu S., and Wooley P.H. Distinct gene expression of receptor activator of nuclear factor-kB and RANK ligand in the inflammatory response to variant morphologies of UHMWPE particles. Biomaterials 24 (2003) 4819-4826
24. Scutt A., and Williamson E.M. Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. Calcif Tissue Int 80 1 (2007) 50-59
25. Karsak M., Cohen-Solal M., Freudenberg J., Ostertag A., Morieux C., Kornak U., et al. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 14 22 (2005) 3389-3396
26. Childs L.M., Paschalis E.P., Xing L., Dougall W.C., Anderson D., Boskey A.L., et al. In vivo RANK signaling blockade using the receptor activateor of NF-kappaB: Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibit osteogenesis. J Bone Miner Res 17 2 (2002) 192-199
27. Bab I., and Zimmer A. Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol 153 2 (2008) 182-188